CUSIP: 03852X100
Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
10,632,740
-
Share change
-
-1,187,096
-
Total reported value
-
$15,951,124
-
Put/Call ratio
-
119%
-
Price per share
-
$1.50
-
Number of holders
-
46
-
Value change
-
-$1,752,034
-
Number of buys
-
19
-
Number of sells
-
21
Quarterly Holders Quick Answers
What is CUSIP 03852X100?
CUSIP 03852X100 identifies ARLZ - ARALEZ PHARMACEUTICALS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q2 2018
-
Previous quarter:
Q4 2017
Recent filing periods for CUSIP 03852X100:
Institutional Holders of ARALEZ PHARMACEUTICALS INC - COM (ARLZ) as of Q1 2018
As of 31 Mar 2018,
ARALEZ PHARMACEUTICALS INC - COM (ARLZ) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,632,740 shares.
The largest 10 holders included
PAR CAPITAL MANAGEMENT INC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), WELLS FARGO & COMPANY/MN, DIMENSIONAL FUND ADVISORS LP, JW Asset Management, LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main, DEUTSCHE BANK AG\, Brown Advisory Securities, LLC, GSA CAPITAL PARTNERS LLP, and SALZHAUER MICHAEL.
This page lists
46
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.